Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations
- PMID: 3003312
- DOI: 10.1002/path.1711480107
Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations
Abstract
Thirty-eight infiltrating ductal carcinomas, nine infiltrating lobular carcinomas, two tubular carcinomas and one papillary carcinoma were studied by light microscopy, immunocytochemistry and electron microscopy. Seventeen cases showed immunoreactivity for NSE. Immunostaining for different peptide-hormones was observed in 12 of these 17 cases and in none of the 10 NSE-negative cases used for controls. Scattered cells were positive for gastrin in five cases, pancreatic polypeptide in five, leu-enkephalin in three, sub-P in two, ACTH in one, bombesin in one and beta-endorphin in one case. Four cases revealed immunoreactivity for more than one peptide-hormone. Typical neuroendocrine granules were seen in five cases (all positively stained for NSE). Small, electron dense granules of possible neuroendocrine nature were not found in any of the 33 NSE-negative tumours. Our results confirm that immunoreactivity for NSE is present in a high proportion of breast carcinomas, but that neuroendocrine differentiation cannot be proved to be present in all these cases.
Similar articles
-
A study of different markers for neuroendocrine differentiation in breast carcinomas.Pathol Res Pract. 1986 Oct;181(5):524-30. doi: 10.1016/S0344-0338(86)80144-3. Pathol Res Pract. 1986. PMID: 2431399
-
Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.J Pathol. 1986 Nov;150(3):181-5. doi: 10.1002/path.1711500306. J Pathol. 1986. PMID: 3027292
-
C-erbB-2 protein and neuroendocrine expression in breast carcinomas.Anticancer Res. 1991 Jan-Feb;11(1):161-7. Anticancer Res. 1991. PMID: 1673329
-
Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.J Pathol. 1985 Dec;147(4):281-9. doi: 10.1002/path.1711470406. J Pathol. 1985. PMID: 3003310
-
Neuroendocrine differentiation in breast lesions.Pathol Res Pract. 1988 Apr;183(2):214-21. doi: 10.1016/S0344-0338(88)80048-7. Pathol Res Pract. 1988. PMID: 3290869 Review.
Cited by
-
Neuroendocrine breast carcinoma: a rare but challenging entity.Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4. Med Oncol. 2020. PMID: 32712767 Free PMC article. Review.
-
Immunohistochemistry of retinoblastomas.J Neurooncol. 1987;5(4):351-5. doi: 10.1007/BF00148392. J Neurooncol. 1987. PMID: 2450182
-
Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.Am J Pathol. 1987 Feb;126(2):243-57. Am J Pathol. 1987. PMID: 3103452 Free PMC article.
-
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.Br J Cancer. 2000 Jan;82(1):20-7. doi: 10.1054/bjoc.1999.0871. Br J Cancer. 2000. PMID: 10638961 Free PMC article.
-
Carcinomas of the breast with endocrine differentiation: a review.Virchows Arch. 1994;425(5):449-57. doi: 10.1007/BF00197547. Virchows Arch. 1994. PMID: 7850068 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical